메뉴 건너뛰기




Volumn 27, Issue 5 SUPPL. 10, 2000, Pages 149-152

Future treatment options with capecitabine

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FLUOROURACIL; FOLIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; TAXANE DERIVATIVE; TAXOL; TAXOTERE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; UFT;

EID: 0033791453     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (3)

References (10)
  • 1
    • 0032127244 scopus 로고    scopus 로고
    • Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
    • (1998) Eur J Cancer , vol.8 , pp. 1274-1281
    • Miwa, M.1    Ura, M.2    Nishida, M.3
  • 4
    • 0030883708 scopus 로고    scopus 로고
    • Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin
    • (1997) J Clin Oncol , vol.15 , pp. 3223-3229
    • Leichman, C.G.1    Lenz, H.J.2    Leichman, L.3
  • 5
    • 0032520168 scopus 로고    scopus 로고
    • Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts
    • (1998) Cancer Res , vol.58 , pp. 685-690
    • Ishikawa, T.1    Sekiguchi, F.2    Fukase, Y.3
  • 7
    • 0026637845 scopus 로고
    • Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules
    • (1992) Cancer Res , vol.52 , pp. 1855-1864
    • Aschele, C.1    Sobrero, A.2    Faderan, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.